EPA:NRO • FR0004050250
We assign a fundamental rating of 6 out of 10 to NRO. NRO was compared to 75 industry peers in the IT Services industry. NRO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. NRO has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROIC | 11.38% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Altman-Z | 4.17 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.39 | ||
| Fwd PE | 14.68 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.48 | ||
| EV/EBITDA | 3.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
EPA:NRO (3/3/2026, 12:50:36 PM)
34.1
-0.25 (-0.73%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.39 | ||
| Fwd PE | 14.68 | ||
| P/S | 1 | ||
| P/FCF | 11.48 | ||
| P/OCF | 9.84 | ||
| P/B | 2.24 | ||
| P/tB | 2.69 | ||
| EV/EBITDA | 3.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.06% | ||
| ROE | 13.65% | ||
| ROCE | 15.78% | ||
| ROIC | 11.38% | ||
| ROICexc | 28.14% | ||
| ROICexgc | 41.95% | ||
| OM | 8.9% | ||
| PM (TTM) | 6.09% | ||
| GM | 99.93% | ||
| FCFM | 8.69% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.57 | ||
| Debt/EBITDA | 0.32 | ||
| Cap/Depr | 66.65% | ||
| Cap/Sales | 1.44% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 91.59% | ||
| Profit Quality | 142.65% | ||
| Current Ratio | 2.31 | ||
| Quick Ratio | 2.31 | ||
| Altman-Z | 4.17 |
ChartMill assigns a fundamental rating of 6 / 10 to NRO.PA.
ChartMill assigns a valuation rating of 4 / 10 to NEURONES (NRO.PA). This can be considered as Fairly Valued.
NEURONES (NRO.PA) has a profitability rating of 6 / 10.
The financial health rating of NEURONES (NRO.PA) is 9 / 10.
The Earnings per Share (EPS) of NEURONES (NRO.PA) is expected to decline by 0% in the next year.